Strategic Initiative

Slingshot members are tracking this corporate initiative:

Allergan (AGN) Exercises $200MM Option to Acquire Motus Therapeutics and Diabetic Gastroparesis (DG) Drug Relamorelin from Rhythm Holding Company, LLC

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Motus Therapeutics

Rhythm Holding Company

Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Oct 27, 2016
Projected Implementation:
Q4, 2016
Relevance Tracked Until:
Q4, 2017
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Option, Diabetic Gastroparesis, Relamorelin, Acquisition